Navigation Links
Novel vaccine shows promise against early-stage breast cancer

A diagnosis of breast cancer has taken on a new meaning in the past 10 years, as research has produced a host of new therapies and detection techniques, significantly improving long-term survival for women who have been fighting the disease. To build on these successes, researchers are now harnessing what they have learned about treating breast cancer and applying it to possible methods of prevention to reduce the total incidence of the disease. One study presented today at the American Association for Cancer Research's Frontiers in Cancer Prevention Research meeting in Boston looks at a specific target in the fight against breast cancer and evaluates a potential vaccine that is yielding promising results for women who are at high-risk for the disease.

Targeted immunoediting of critical pathways responsible for breast cancer development: treatment of early breast cancer using HER-2/neu pulsed dendritic cells

Multiple genetic targets have been discovered that may help fight breast cancer, including BRCA, estrogen receptors, and HER-2/neu, all of which have been known to predict the severity of disease, recurrence and overall survival. Developing novel therapies that target these specific genetic variances may be extremely beneficial in preventing breast cancer for many women.

In this study, researchers investigated a potential vaccine that targets HER-2/neu over-expression in early stage breast cancer, known as DCIS (ductal carcinomas in situ, or early stage cancer formation in the breast's milk ducts). It is estimated at 50-60 percent of DCIS is directly related to HER-2/neu over-expression.

Patients with HER-2/neu overexpression were given a therapy of dendritic cells (DC, which work with the B- and T-cells to trigger immune responses) that were treated with HER-2/neu to evoke an immune response. The participants received four weekly vaccinations into normal lymph nodes in their groins and were evaluated both pre- and po
'"/>

Source:American Association for Cancer Research


Page: 1 2

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Novel technology detects human DNA mutations
3. Novel antiviral technology inhibits RSV infection in mice
4. Novel Enzyme Shows Potential As An Anti-HIV Target
5. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
6. Discovery Could Lead To Novel Approaches In HIV Treatment
7. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
8. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
9. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma
10. Novel live reporting system to track cells
11. Field of beams - Novel system uses polarized light pulses to reveal crop health
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Novel vaccine shows promise against early stage breast cancer

(Date:6/18/2013)... Obar, Ph.D., Department of Immunology and Infectious Diseases, Montana ... Young Investigator Award for his research on factors affecting ... , Obar earned his B.A. in Microbiology from ... complete his Ph.D. in Microbiology and Immunology from Dartmouth ... research in Edward Usherwood,s laboratory at the Geisel School ...
(Date:6/18/2013)... is estimated that between 5% and 10% of breast ... to say that these tumours are attributable to inherited ... or BRCA2. In patients with these mutations, PARP inhibitors, ... results that make them a new option for personalised ... latest studies indicate that a fraction of these patients ...
(Date:6/18/2013)... that weight gain and increased head size in the first month ... early school age. , The study was led by University of ... children who were born full-term. , The results, published in the ... on 40% of their birthweight in the first four weeks had ... years of age, compared with babies who only put on 15% ...
Breaking Biology News(10 mins):The American Society for Microbiology honors Joshua Obar 2An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2IQ link to baby's weight gain in first month 2
... known that excessive text messaging can result in sore thumbs, ... arms and hands. Young adults with symptoms in these parts ... to a study at the Sahlgrenska Academy, University of Gothenburg, ... 56 young adults who text message on a daily basis. ...
... warming whips up more powerful and frequent hurricanes and storms, ... to breed and recover from damage. That,s one of ... of corals in the wake of large climate-driven bleaching and ... recruitment the regrowth of young corals drops sharply ...
... San Jose, California, June 23, 2009 Chronix ... peer-reviewed journal further confirms the potential diagnostic and prognostic ... early stage disease. These DNA fragments, referred to ... in trace amounts during the disease process. Chronix Biomedical ...
Cached Biology News:How to text message and avoid pain 2Coral face 'a stormy future' 2Study shows Chronix technology using serum DNA can identify early presence of disease 2
(Date:6/20/2013)... Dental decay is the number one ... For Dr. Crisafulli of Crisafulli Dental those statistics are no ... the world and implemented a cavity prevention program developed by ... by up to 74% . The system is ... finally found a solution to dental decay that works,” says ...
(Date:6/19/2013)... IL (PRWEB) June 19, 2013 For ... offers Waterless Bead Baths using metallic beads ... less electricity, and do not require germicides. Yet, the ... and, because the bath is always ready unlike a ... beads create a dry bath, which eliminates the contamination ...
(Date:6/19/2013)... 2013 Research and ... addition of the "Global Biometric Systems ... to their offering.      (Logo: ... protection and old security practises such as ... the growth of biometric technologies in last ...
(Date:6/19/2013)... 19, 2013  Continuing its long history of proven ... Beckman Coulter , Inc. announces the U.S. Food and ... AccuTnI+3 troponin I assay for use on its Access ... on Beckman Coulter,s troponin I test for ... the proven performance to continue providing dependability to laboratories ...
Breaking Biology Technology:Crisafulli Dental Launches Ground Breaking Cavity Prevention Program That Can Lower Decay Rates by 74% 2Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths 2Global Biometric Systems Market Forecast Report - Opportunities to 2018 2Global Biometric Systems Market Forecast Report - Opportunities to 2018 3Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3
... ValGenesis, Inc., a world-class provider of Validation Lifecycle ... ValGenesis Suite 2.5 has achieved SAP certification as ... this certified integration status deepens ValGenesis, active and ... SAP Integration and Certification Center (SAP ICC) has ...
... BioLife Solutions , Inc. (OTCBB: BLFS), a leading ... hypothermic storage and cryopreservation freeze ... that TRANSFUSION , the foremost publication in ... has published a peer-reviewed journal article reporting positive ...
... Inspired Engineering at Harvard University have developed a robotic ... specific cell targets within a complex mixture of cell ... cancer cells to self-destruct. Inspired by the mechanics of ... day be used to program immune responses to treat ...
Cached Biology Technology:ValGenesis Suite 2.5 Certified by SAP as Powered by SAP NetWeaver® 2ValGenesis Suite 2.5 Certified by SAP as Powered by SAP NetWeaver® 3Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION 2Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION 3Improved Cord Blood Processing Research on BioLife Solutions CryoStor® Published in TRANSFUSION 4Harvard's Wyss Institute develops DNA nanorobot to trigger targeted therapeutic responses 2Harvard's Wyss Institute develops DNA nanorobot to trigger targeted therapeutic responses 3
Request Info...
Polyclonal Antibody to CLAN...
Goat polyclonal to MLH3 ( Abpromise for all tested applications). entrezGeneID: 27030 SwissProtID: Q9UHC1...
Rabbit polyclonal to NMDAR1 e/f/g/h ( Abpromise for all tested applications)....
Biology Products: